Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Nov 07, 2017

SELL
$55.23 - $63.74 $2.01 Million - $2.32 Million
-36,400 Closed
0 $0
Q2 2016

Oct 03, 2017

BUY
N/A
36,400
36,400 $2.69 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ironsides Asset Advisors, LLC Portfolio

Follow Ironsides Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironsides Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironsides Asset Advisors, LLC with notifications on news.